Jim Simons's position in Gilead Sciences is currently worth $600 Million. That's 0.89% of their equity portfolio (7th largest holding). The first Gilead Sciences trade was made in Q2 2013. Since then Jim Simons bought shares 23 more times and sold shares on 23 occasions. The stake costed the investor $404 Million, netting the investor a gain of 49% so far.
In this article we take a look at Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks. Click to skip ahead and see Jim Simons Stock Portfolio: 5 Biggest...
Jim Simons is the founder and hedge fund manager of Renaissance Technologies, which currently has a total portfolio value north of $77 billion, per Stock Cir...